Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. JAMA : the journal of the American Medical Association [JAMA] Journal article

Title	Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Author(s)	Costenbader KH, Glass R, Cui J, Shadick N
Source	JAMA 2006 Nov 8; 296(18):2201; author reply 2203-4.
MeSH	Antibodies, Monoclonal Antirheumatic Agents Arthritis, Rheumatoid Biological Response Modifiers Humans Risk Tumor Necrosis Factor-alpha
Language	eng
Pub Type(s)	Comment Letter
PubMed ID	17090761

Advertise on this site.